Skip to content

Clinical trials

Phase 3 Pituitary Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pituitary Diseases Phase: Phase 3 Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20063
20071
20091
20101
20151
20162
20172
20192
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Not yet recruiting1
Recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Corcept Therapeutics3
Ascendis Pharma Endocrinology Division A/S2
LG Life Sciences2
Ascendis Pharma A/S1
Assistance Publique - Hôpitaux de Paris1
Debiopharm International SA1
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
Göteborg University1
Ipsen1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pituitary Diseases16
Dwarfism, Pituitary6
Pituitary ACTH Hypersecretion5
Endocrine System Diseases4
Failure to Thrive4
ACTH Syndrome, Ectopic3
Acromegaly3
Cushing Syndrome3
Adrenal Cortex Neoplasms2
Choristoma2

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.